Table 2 Survival analysis of NTN4 mRNA in breast cancer patients (the Prognoscan).
From: NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer
Dataset | Endpoint | Number | ln(HRhigh/HRlow) | COX P-value | ln(HR) | HR[95% CIlow CIupp] |
|---|---|---|---|---|---|---|
GSE6532-GPL570 | Relapse Free Survival | 87 | − 1.54 | 0.008389 | − 0.23 | 0.79[0.66–0.94] |
Distant Metastasis Free Survival | 87 | − 1.54 | 0.008389 | − 0.23 | 0.79[0.66–0.94] | |
GSE1379 | Relapse Free Survival | 60 | − 1.64 | 0.033113 | − 0.27 | 0.76[0.59–0.98] |
GSE3494-GPL97 | Distant Specific Survival | 236 | − 1.15 | 0.004196 | − 0.38 | 0.68[0.52–0.89] |
GSE4922-GPL97 | Distant Free Survival | 249 | − 0.97 | 0.043828 | − 0.21 | 0.81[0.66–0.99] |
